Using NMR, we have previously reported altered choline metabolism in response to inhibition of the PI3K signaling pathway with LY294002, wortmannin and the selective dual pan-Class I PI3K/mTOR inhibitor PI-103 in adult human cancer cell models [24], [25]. Here, PIK3CA is linked to cancer.